American Heart News - Heart News
MARCH 18, 2024
Research Highlights: A study of over 20,000 adults found that those who followed an 8-hour time-restricted eating schedule, a type of intermittent fasting, had a 91% higher risk of death from cardiovascular disease. People with heart disease or cancer.
DAIC
MARCH 18, 2024
milla1cf Mon, 03/18/2024 - 07:00 March 18, 2024 — Conformal Medical, Inc. announced that the CLAAS System was featured in a podium presentation at the Cardiovascular Research Technologies (CRT) 2024 conference. Dr. William Gray , Professor of Medicine, Thomas Jefferson University, System Chief, Cardiovascular Diseases at Main Line Health , and Co-Director Lankenau Heart Institute presented "Comparative Acute Thrombogenicity of The CLAAS Foam Implant and Watchman FLX In An In Vitro Blood Loop M
HCPLive
MARCH 18, 2024
Aquatic therapy for women with fibromyalgia in Spain is better than land-based therapy for reducing pain levels and improving sleep quality, as seen at the 6-week follow-up.
DAIC
MARCH 18, 2024
milla1cf Mon, 03/18/2024 - 07:30 March 18, 2024 — SS Innovations International, Inc. , a developer of innovative surgical robotic technologies dedicated to making world class robotic surgery affordable and accessible to a global population, today announced that surgeons have successfully performed the world’s first mitral valve replacement using the Made in India, SSi Mantra Surgical Robotic System.
Frontiers in Cardiovascular Medicine
MARCH 18, 2024
Heart failure, a prevailing global health issue, imposes a substantial burden on both healthcare systems and patients worldwide. With an escalating prevalence of heart failure, prolonged survival rates, and an aging demographic, an increasing number of individuals are progressing to more advanced phases of this incapacitating ailment. Against this backdrop, the quest for pharmacological agents capable of addressing the diverse subtypes of heart failure becomes a paramount pursuit.
DAIC
MARCH 18, 2024
milla1cf Mon, 03/18/2024 - 08:00 March 18, 2024 — The Smidt Heart Institute at Cedars-Sinai recently became one of four institutions in the U.S. and the first on the West Coast to use a new device aimed at lowering blood pressure in patients with difficult-to-treat hypertension. Cedars-Sinai is part of a clinical trial testing the safety and efficacy of the device, which is now commercially available after the U.S.
Med Page Today
MARCH 18, 2024
(MedPage Today) -- Patients with SGLT2 inhibitor-associated diabetic ketoacidosis (DKA) received significantly lower doses of insulin in the first 24 hours of treatment compared with patients with type 1 diabetes DKA, according to a retrospective.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
HCPLive
MARCH 18, 2024
Eiran Gorodeski, MD, MPH, Parag Goyal, MD, MSc, and James Fang, MD, discuss the HFSA's recent scientific statement on the prevalence and impact of cognitive impairment on the management of heart failure.
Medical Xpress - Cardiology
MARCH 18, 2024
A five-day course of once-daily inorganic nitrate reduces the risk of a serious complication following a coronary angiogram, in which the dye used causes damage to the kidneys. The clinical trial, led by Queen Mary University of London, also showed that the five-day course improves renal outcomes at three months and major adverse cardiac events (MACE) at one year compared to placebo.
Becker's Hospital Review - Cardiology
MARCH 18, 2024
Vaccines for coronary artery disease and a program that keeps a bed open for critical heart patients are just two elements of his field that light a fire under Vincent Sorrell, MD.
Medical Xpress - Cardiology
MARCH 18, 2024
A blood test could help identify those at highest risk of dying from heart failure, new research has found. The study found that patients with highest levels of a protein called neuropeptide Y (NPY) were 50% more likely to die from a heart complication over the three years that the research was conducted, compared to those with lower levels.
Science Daily - Heart Disease
MARCH 18, 2024
Coronary heart disease is a major global health problem, especially among people with type 2 diabetes. Researchers have identified novel protein biomarkers that are associated with the development of CHD in people with and without diabetes.
Medical Xpress - Cardiology
MARCH 18, 2024
Heparin, the world's most widely used blood thinner, is used during procedures ranging from kidney dialysis to open heart surgery. Currently, heparin is derived from pig intestines, but scientists at Rensselaer Polytechnic Institute (RPI) have discovered how to make it in the lab. They have also developed a path to a biomanufacturing process that could potentially revolutionize how the world gets its supply of this crucial medicine.
American College of Cardiology
MARCH 18, 2024
What is the prevalence and what are the survival outcomes of patients with discordant high-gradient aortic stenosis (DHG-AS; defined as mean gradient [MG] ≥40 mm Hg and effective orifice area [EOA] >1.0 cm2)?
Medical Xpress - Cardiology
MARCH 18, 2024
A new Viewpoint article published in the Journal of the American Medical Association (JAMA), titled " Use of Lecanemab for Patients with Cardiovascular Disease—The Challenge of Uncertainty," advocates for additional research to improve decision making prior to initiating lecanemab, commercially known as Leqembi, an FDA-approved Alzheimer's Disease drug.
HCPLive
MARCH 18, 2024
In part 1 of this 5-part video series, our experts in hepatology discuss the recent change in nomenclature for NASH/NAFLD as compared to MASH/MASLD and how it effects management.
Medical Xpress - Cardiology
MARCH 18, 2024
People at risk should be tested for atrial fibrillation every time they attend a health appointment, according to results of the AFFECT-EU project, which is holding its final event today in Brussels, Belgium. Patients at high risk of the disorder, such as those with heart failure or prior stroke, should be invited for a screening test.
HCPLive
MARCH 18, 2024
Harrison discusses important lessons from obeticholic acid’s FDA failure and what set resmetirom apart from its predecessor, poising it to become the first FDA-approved NASH treatment.
Medical Xpress - Cardiology
MARCH 18, 2024
Coronary heart disease (CHD) is one of the most common causes of death worldwide—especially in Europe: Here, it is responsible for nearly half of all deaths. Among middle-aged adults, individuals with type 2 diabetes (T2D) have a two to four times higher risk of developing CHD than people without T2D. The research team investigated the predictive performance of protein biomarkers on incident CHD in individuals with and without T2D.
Becker's Hospital Review - Cardiology
MARCH 18, 2024
Philadelphia-based University of Pennsylvania researchers found the number of heart transplant emergency department visits increased with high admission rates but low in-hospital mortality rates.
HCPLive
MARCH 18, 2024
In the final installment in our 5-part video series, our pair of experts in hepatology touch upon how an approval for MASH would impact conversations around screening for asymptomatic patient populations.
Med Page Today
MARCH 18, 2024
(MedPage Today) -- American societies endorsed five performance measures in valvular and structural heart disease that may be used for public reporting and pay-for-performance programs. (Circulation: Cardiovascular Quality and Outcomes) People.
HCPLive
MARCH 18, 2024
A new study found late baby boomers and Generation X reported greater levels of loneliness than early baby boomers and the Silent Generation.
American College of Cardiology
MARCH 18, 2024
What is the association between antiarrhythmic drug (AAD) use and the risk of pacemaker implantation or syncope in patients with new-onset atrial fibrillation (AF) receiving early rhythm control therapy with AADs?
HCPLive
MARCH 18, 2024
Harrison discusses the role of GLP-1-based therapies in NASH management and situations where resmetirom may be a better option following its recent FDA approval.
Medical Xpress - Cardiology
MARCH 18, 2024
Portal hypertension (PHT) is a severe complication of chronic liver disease, like cirrhosis, where increased pressure builds up in the portal vein. This major blood vessel drains blood from the intestines, spleen, and stomach to the liver. This can lead to life-threatening complications such as internal bleeding and liver failure.
HCPLive
MARCH 18, 2024
These data highlight the risk of anxiety and depression among dermatologists, with notable findings based on gender differences observed among clinicians.
ADN Center of Excellence
MARCH 18, 2024
In the dynamic realm of interventional cardiology, education is the cornerstone of excellence. ADN CoE recently hosted a groundbreaking Mitral & Tricuspid Valve Interventions Training, uniting cardiologists from around the globe for an immersive learning experience. Today, we're excited to share the highlights and successes of this transformative event.
Journal of Cardiothoracic Surgery
MARCH 18, 2024
Left atrial dissection (LAtD) is a rare but potentially life-threatening complication of mitral valve surgery. Its management is not well stablished in the literature. However, early recognition through intrao.
Dr. Paddy Barrett
MARCH 18, 2024
My iPhone is the most inexpensive item I have bought in the last year. By a mile. It's not that I have an old one or that I got it second-hand. It's the latest version, and I paid full price for it. Why is it so cheap? Because of how much value I get from it. On a per-use basis and for what I use it for, it provides insane value. Price is what you pay.
Journal of Cardiothoracic Surgery
MARCH 18, 2024
Coronary artery obstruction after percutaneous aortic replacement is a complication with high short-term mortality secondary to the lack of timely treatment. There are various predictors of coronary obstructio.
All About Cardiovascular System and Disorders
MARCH 18, 2024
Transcript of the video: Interpreting an echo quiz just from a single frame has a lot of limitations. But, still for an academic exercise, we will try. Unlike the ECG, where a single image may be more informative, echo usually requires moving images. And moreover, even ECG requires a knowledge of the clinical background before interpretation, to avoid errors.
Journal of Cardiothoracic Surgery
MARCH 18, 2024
We investigated long-term outcomes, particularly later aorta operations and overall death in patients who underwent aortic valve replacement for bicuspid aortic valve without aortic surgery.
All About Cardiovascular System and Disorders
MARCH 18, 2024
Transcript of the video: A question that is often asked is, what is the meaning of 10% gradient in a treadmill test? Usually, in the first stage of Bruce protocol, of treadmill test, there is a 10% gradient in stage 1. That means, if the treadmill length is 150 centimeters, the front end is elevated, about 15 cm from the ground, so that this produces a slope.
Physiologically Speaking
MARCH 18, 2024
Listen to the podcast (audio-only) version here. Dr. Elisabeth Bik is a microbiome scientist. She received her PhD from Utrecht University in the Netherlands. Her scientific work has included time at the Dutch National Institute for Health and the Stanford University School of Medicine.
All About Cardiovascular System and Disorders
MARCH 18, 2024
Transcript of the video: Here is an X-ray chest PA view. The striking finding is the huge enlargement of the right pulmonary artery, almost aneurysmal dilatation of right pulmonary artery. Main pulmonary artery is also grossly dilated. And you can see left pulmonary artery shadow and rest of it is not seen here. It will be behind the main pulmonary artery shadow, because left pulmonary artery descends behind the main pulmonary artery and it will be a retrocardiac shadow.
Dr. Paddy Barrett
MARCH 18, 2024
When medical interventions are being evaluated for cost-effectiveness, the benchmark for one additional quality year of life is $50,000. This is known as a QALY or Quality Adjusted Life Year. If the intervention costs less than $50,000 per year to provide an additional quality year, it is considered cost-effective. Of course, this is a somewhat arbitrary figure, but we have to start somewhere.
Expert insights. Personalized for you.
145 
Let's personalize your content